Literature DB >> 26221283

Association of COX-2 -765G>C genetic polymorphism with coronary artery disease: a meta-analysis.

Ming-Ming Zhang1, Xiang Xie1, Yi-Tong Ma1, Ying-Ying Zheng1, Yi-Ning Yang1, Xiao-Mei Li1, Zhen-Yan Fu1, Fen Liu1, Bang-Dang Chen1.   

Abstract

BACKGROUND: Previous studies suggested the single nucleotide polymorphism (SNP) of COX-2 -765G>C (rs20417) is associated with coronary artery disease (CAD), but the results were conflicting. In order to derive a more precise estimation of the associations, we performed a meta-analysis of the relationship between rs20417 and CAD in all published studies.
METHOD: Databases including PubMed, Web of Science, Wanfang, SinoMed and CNKI were systematically searched. Data were extracted using standardized methods. The association was assessed by odds ratio (OR) with 95% confidence intervals (CIs).The statistical tests were performed using Review Manager 5.3.3 and Stata 12.0 software.
RESULTS: We identified a total of 14 studies involving a total of 18227 subjects. The pooled odds ratio (OR) for the association between COX-2 -765G>C and CAD and its corresponding 95% confidence interval (95% CI) were evaluated by random or fixed effect model. A significant statistical association between COX-2 -765G>C and CAD was observed in an allelic model (P=0.02, OR=0.64, 95% CI: 0.43-0.94), dominant model (P=0.04, OR=0.74, 95% CI: 0.56-0.99), and recessive model (P=0.02, OR=0.46, 95% CI: 0.23-0.90).
CONCLUSION: This meta-analysis suggested that COX-2 -765G>C is a protective for CAD.

Entities:  

Keywords:  PTGS2; coronary heart disease; meta-analysis; polymorphism

Year:  2015        PMID: 26221283      PMCID: PMC4509228     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population.

Authors:  Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Zhen-Yan Fu; Xiao-Mei Li; Ding Huang; Xiang Ma; Bang-dang Chen; Fen Liu
Journal:  Clin Chem Lab Med       Date:  2010-11-22       Impact factor: 3.694

2.  Cyclooxygenase-2 inhibitors and coronary occlusion--exploring dose-response relationships.

Authors:  Patricia McGettigan; Pearline Han; David Henry
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

3.  Induction of prostacyclin/PGI2 synthase expression after cerebral ischemia-reperfusion.

Authors:  Yao-Ching Fang; Jui-Sheng Wu; Jean-Ju Chen; Wai-Mui Cheung; Ping-Hui Tseng; Ka-Bik Tam; Song-Kun Shyue; Jin-Jer Chen; Teng-Nan Lin
Journal:  J Cereb Blood Flow Metab       Date:  2006-04       Impact factor: 6.200

4.  Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

Authors:  Anastasia Papafili; Michael R Hill; David J Brull; Robin J McAnulty; Richard P Marshall; Steve E Humphries; Geoffrey J Laurent
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

5.  Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.

Authors:  J Orbe; O Beloqui; J A Rodriguez; M S Belzunce; C Roncal; J A Páramo
Journal:  Clin Chim Acta       Date:  2006-02-03       Impact factor: 3.786

Review 6.  Colon cancer prevention by NSAIDs: what is the mechanism of action?

Authors:  D J Ahnen
Journal:  Eur J Surg Suppl       Date:  1998

7.  Polymorphisms cyclooxygenase-2 -765G>C and interleukin-6 -174G>C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts.

Authors:  Dolores Corella; José Ignacio González; Mònica Bulló; Paula Carrasco; Olga Portolés; Javier Díez-Espino; María Isabel Covas; Valentina Ruíz-Gutierrez; Enrique Gómez-Gracia; Fernando Arós; Miquel Fiol; Manuel Conde Herrera; José Manuel Santos; Guillermo Sáez; Rosa Lamuela; Carlos Lahoz; Ernest Vinyoles; Emilio Ros; Ramón Estruch
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

8.  [Study on the association of cyclooxygenase-2 -765g>C and prostacyclin synthase C1117A polymorphisms and the risk of myocardial infarction in Uigur population of Xinjiang, China].

Authors:  Xiang Xie; Yi-Tong Ma; Zhen-Yan Fu; Yi-Ning Yang; Ying-Hong Wang; Bang-Dang Chen; Fen Liu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2008-06

9.  A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.

Authors:  Francesco Cipollone; Elena Toniato; Stefano Martinotti; Maria Fazia; Annalisa Iezzi; Chiara Cuccurullo; Barbara Pini; Sebastiano Ursi; Gianfranco Vitullo; Maurizio Averna; Marcello Arca; Anna Montali; Filomena Campagna; Sante Ucchino; Francesco Spigonardo; Stefano Taddei; Agostino Virdis; Giovanni Ciabattoni; Alberto Notarbartolo; Franco Cuccurullo; Andrea Mezzetti
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

10.  The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia.

Authors:  Donatella Colaizzo; Laura Fofi; Gianluca Tiscia; Renzo Guglielmi; Nicola Cocomazzi; Massimiliano Prencipe; Maurizio Margaglione; Danilo Toni
Journal:  Blood Coagul Fibrinolysis       Date:  2006-03       Impact factor: 1.276

View more
  4 in total

1.  COX-1, COX-2 and CYP2C19 variations may be related to cardiovascular events due to acetylsalicylic acid resistance.

Authors:  Deniz Kirac; Aysun Erdem Yaman; Tansu Doran; Mujgan Mihmanli; Elif Cigdem Keles
Journal:  Mol Biol Rep       Date:  2022-01-09       Impact factor: 2.316

2.  Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region.

Authors:  Samuel B Anyona; Nicolas W Hengartner; Evans Raballah; John Michael Ong'echa; Nick Lauve; Qiuying Cheng; Paul W Fenimore; Collins Ouma; Christophe G Lambert; Benjamin H McMahon; Douglas J Perkins
Journal:  J Hum Genet       Date:  2019-10-29       Impact factor: 3.172

Review 3.  Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis.

Authors:  Li Xie; You-Mei Li
Journal:  Int J Environ Res Public Health       Date:  2017-01-16       Impact factor: 3.390

4.  Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism.

Authors:  Sook Joung Lee; Min Kyu Park; Dong-Seong Shin; Min Ho Chun
Journal:  Drug Des Devel Ther       Date:  2017-09-13       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.